Drug errors involving Temodar
Q&A: Strategic Vaccine Management Can Drive Pharmacy Success | AAP 2025
A conversation with Greg Mitchell, owner of United Drug Superstore in Hatch, New Mexico, at AAP 2025.
Wicked Good Cardiometabolic Chat: Compounded Weight Loss Medications
In the first episode of the podcast, Jennifer Goldman and Hailey Choi discuss the latest FDA updates around compounded weight loss medications, clinical concerns and how pharmacists can protect their patients.
GLP-1 Medications Continue to Increase Market Growth | Asembia 2025
Glucagon-like peptide-1 medications are the fastest-growing class of medication and will continue to be prevalent as more indications, such as sleep apnea, are added.
The Current State Of OTC Medication Use for Pain Management
Leveraging his expertise in pain management, Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, joined Drug Topics to discuss the importance of pharmacists in patients’ use of OTC medications to treat pain.
Yuflyma Demonstrates Continued Interchangeability with Humira
Results are from an open-label extension of a phase 3 trial assessing the pharmacokinetics, efficacy, safety, and immunogenicity of adalimumab-aaty and its reference formulation Humira.
Community Specialty Pharmacies Can Make Patient Journey Easier | Asembia 2025
The role of the community pharmacist is beginning to expand into specialty pharmacy spaces to increase access and outcomes for patients.
